menu
    • menu

    Company profile for Lirum Therapeutics

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lirum Therapeutics is an innovative biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development and commercialization of novel drug candidates with compelling mechanisms of action, regulatory pathways and commercial opportunities. Our goal is to build a leading biopharmaceutical company focused on improving the lives of patients with difficult-to-treat diseases by developin...
    Lirum Therapeutics is an innovative biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development and commercialization of novel drug candidates with compelling mechanisms of action, regulatory pathways and commercial opportunities. Our goal is to build a leading biopharmaceutical company focused on improving the lives of patients with difficult-to-treat diseases by developing and commercializing novel first-in-class therapeutics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lirum TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    590 Madison Avenue 21st Floor New York, NY 10022
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lirumtx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lirum Therapeutics Presents Positive LX-101 Data at AACR 2026
    Lirum Therapeutics Presents Positive LX-101 Data at AACR 2026

    20 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7190258

    FIRSTWORD PHARMA
    20 Apr 2026
    Share Share
    Lirum Gets FDA Go-Ahead to Add LX-101 to RAPID Trial for Sarcoma
    Lirum Gets FDA Go-Ahead to Add LX-101 to RAPID Trial for Sarcoma

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169787/0/en/Lirum-Therapeutics-Announces-FDA-Study-May-Proceed-Letter-Enabling-Inclusion-of-LX-101-in-the-RAPID-Platform-Clinical-Trial-for-Ewing-Sarcoma-and-Desmoplastic-Small-Round-Cell-Tumo.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    Lirum Therapeutics: LX-101 Data in Thyroid Eye Disease at ARVO
    Lirum Therapeutics: LX-101 Data in Thyroid Eye Disease at ARVO

    07 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/07/3075923/0/en/Lirum-Therapeutics-Announces-New-LX-101-Data-in-Thyroid-Eye-Disease-Selected-for-Presentation-at-the-Association-for-Research-in-Vision-and-Ophthalmology-ARVO-2025-Annual-Meeting.html

    GLOBENEWSWIRE
    07 May 2025
    Share Share
    Lirum Therapeutics' LX-101 Positive Data at 2025 AACR Meeting
    Lirum Therapeutics' LX-101 Positive Data at 2025 AACR Meeting

    29 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/29/3070523/0/en/Lirum-Therapeutics-LX-101-New-Positive-Data-Selected-for-Presentation-at-the-2025-American-Association-for-Cancer-Research-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    29 Apr 2025
    Share Share
    Lirum Therapeutics Invited To Present At Gordon Conf
    Lirum Therapeutics Invited To Present At Gordon Conf

    19 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/19/3045389/0/en/Lirum-Therapeutics-Invited-to-Present-at-Prestigious-Gordon-Research-Conference.html

    GLOBENEWSWIRE
    19 Mar 2025
    Share Share
    Lirum Therapeutics debuts LX-101 results in Thyroid Eye Disease
    Lirum Therapeutics debuts LX-101 results in Thyroid Eye Disease

    17 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/17/3043688/0/en/Lirum-Therapeutics-Announces-Debut-of-LX-101-Results-in-Thyroid-Eye-Disease-Selected-for-Presentation-at-the-2025-NANOS-Annual-Meeting.html

    GLOBENEWSWIRE
    17 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search